No one in America should have to worry about going bankrupt when they get sick or choose between filling their prescription and paying for necessities like food and rent. However, government policies so far, have fallen short of reigning in the ever-increasing costs of prescription drugs. We need to rebalance incentives to increase innovation and price competition and prioritize patient access and affordability. Ultimately, we need to ensure that Americans can access the prescription drugs they need at prices they can afford.
West Health focuses on developing evidence-based solutions with partners from the worlds of healthcare, business, policy, and academia to drive forward change. Below is a collection of our work to help advance the drug pricing debate.
Research and Analysis
Original research and policy analysis conducted by West Health’s experts on drug spending.
To provide clear and unbiased information about the implications of drug pricing policies on consumers, industry, and the country, West Health formed CIDSA, the Council for Informed Drug Spending Analysis.
Featured Opinions From CIDSA, a nine-member panel comprised of the nation’s leading drug spending experts
West Health does not accept unsolicited business plans or proposals.
We are dedicated to lowering healthcare costs to enable seniors to successfully age in place with access to high-quality, affordable health and support services that preserve and protect their dignity, quality of life and independence.